# FR Doc. 2024-30261: Nonprescription Drug Product With an Additional Condition for Nonprescription Use

FR Doc. 2024-30261: Nonprescription Drug Product With an Additional Condition for Nonprescription Use, “Nonprescription Drug Product With an Additional Condition for Nonprescription Use”, is a Federal Register rule, by [Department of Health and Human Services](https://ontology.bommaritollc.com/id/01a0ee04-de46-77c7-8aa0-7ec78a97ca63).

IRI: <https://ontology.bommaritollc.com/id/01a110b3-e4cd-765a-8ff9-8ee3a79ad81a>

Within: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0) › [Government of United States](https://ontology.bommaritollc.com/id/01a0ee04-ddfb-711a-a65c-9de9ee96b9ab) › [Department of Health and Human Services](https://ontology.bommaritollc.com/id/01a0ee04-de46-77c7-8aa0-7ec78a97ca63) › [Food and Drug Administration](https://ontology.bommaritollc.com/id/01a0ee04-de4b-7716-87b1-13a337b6119f)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [us-fr-document 2024-30261](https://ontology.bommaritollc.com/id/01a110b3-e4ce-779e-912a-d69edc3126ee)
- `dcterms:bibliographicCitation`: 89 FR 105288
- `dcterms:issued`: 2024-12-26 (xsd:date)
- `eli:changes`:
  - [21 CFR Part 201—Labeling](https://ontology.bommaritollc.com/id/01a0f094-b837-76de-94de-1fdabf2c1fc1)
  - [21 CFR Part 314—Applications for FDA approval to market a new drug](https://ontology.bommaritollc.com/id/01a0f094-b84d-7031-b149-cb632d656858)
- `eli:first_date_entry_in_force`: 2025-01-27 (xsd:date)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/FR-2024-12-26/2024-30261](https://ontology.bommaritollc.com/id/01a110b3-e4cd-765a-8ff9-8ee241c83821)
  - [evidence from https://www.govinfo.gov/app/details/FR-2024-12-26/2024-30261](https://ontology.bommaritollc.com/id/01a127b2-45ea-773c-b6c0-457f605009b3)
- `schema:legislationIdentifier`: FR Doc. 2024-30261
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationPassedBy`:
  - [Department of Health and Human Services](https://ontology.bommaritollc.com/id/01a0ee04-de46-77c7-8aa0-7ec78a97ca63)
  - [Food and Drug Administration](https://ontology.bommaritollc.com/id/01a0ee04-de4b-7716-87b1-13a337b6119f)
- `schema:legislationType`: [Federal Register rule](https://ontology.bommaritollc.com/vocab/leg/federalRegisterRule)
- `schema:name`: Nonprescription Drug Product With an Additional Condition for Nonprescription Use
- `schema:url`: [https://www.govinfo.gov/app/details/FR-2024-12-26/2024-30261](https://www.govinfo.gov/app/details/FR-2024-12-26/2024-30261)
- `skos:prefLabel`: FR Doc. 2024-30261: Nonprescription Drug Product With an Additional Condition for Nonprescription Use

## Elsewhere

- [Official page](https://www.govinfo.gov/app/details/FR-2024-12-26/2024-30261) (www.govinfo.gov)

## Pointing here

- Its event of, from (2; `bcleg:eventOf`):
  - [FR Doc. 2024-30261: in force 2025-01-27](https://ontology.bommaritollc.com/id/01a127b5-6dcc-76eb-9f40-50e814a5966e)
  - [FR Doc. 2024-30261: published 2024-12-26](https://ontology.bommaritollc.com/id/01a127b5-6dcb-7586-b4be-94feeabea6b2)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a110b3-e4cd-765a-8ff9-8ee3a79ad81a.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a110b3-e4cd-765a-8ff9-8ee3a79ad81a.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a110b3-e4cd-765a-8ff9-8ee3a79ad81a.nt), [HTML](https://ontology.bommaritollc.com/id/01a110b3-e4cd-765a-8ff9-8ee3a79ad81a)
Cite as: FR Doc. 2024-30261: Nonprescription Drug Product With an Additional Condition for Nonprescription Use. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a110b3-e4cd-765a-8ff9-8ee3a79ad81a
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
